# B4GALNT1

## Overview
The B4GALNT1 gene encodes the enzyme beta-1,4-N-acetyl-galactosaminyltransferase 1, a glycosyltransferase involved in the biosynthesis of gangliosides, which are essential glycosphingolipids in cellular membranes, particularly within neural tissues. This enzyme catalyzes the transfer of N-acetylgalactosamine to glycolipids, facilitating the production of complex gangliosides that play critical roles in cell signaling and neural function (Inamori2024Functional; Alecu2022Functional). The protein is primarily localized in the Golgi apparatus, where it contributes to the stability and function of myelinated axons, crucial for normal neurological processes (Inamori2024Functional). Mutations in B4GALNT1 are linked to hereditary spastic paraplegia type 26, highlighting its significance in maintaining neurological health (Boukhris2013Alteration).

## Structure
The B4GALNT1 protein, also known as beta-1,4-N-acetyl-galactosaminyltransferase 1, is involved in the synthesis of glycosphingolipids. Its primary structure includes a signal peptide and a transmembrane domain, with a molecular weight of 58,882.38 Da and a theoretical isoelectric point (pI) of 8.93, classifying it as an unstable protein (Dad2017Structural). The secondary structure of B4GALNT1 features alpha helices, transmembrane helices, and beta strands, as predicted by the Phyre2.0 program (Dad2017Structural).

The tertiary structure was modeled using bioinformatics tools, with 335 residues modeled with over 90% accuracy. The model was evaluated for quality, showing 61.9% of residues in the most favored regions according to PROCHECK, and a ProSA Z-score of -5.44 (Dad2017Structural). The protein undergoes several post-translational modifications, including N-linked glycosylation at positions 79, 179, and 274, and mucin-type O-GalNAc glycosylation at positions 45, 115, 492, and 493. Phosphorylation sites for serine, threonine, and tyrosine are also predicted (Dad2017Structural). No quaternary structure or splice variant isoforms are mentioned in the available data (Dad2017Structural).

## Function
The B4GALNT1 gene encodes the enzyme beta-1,4-N-acetyl-galactosaminyltransferase 1, also known as GM2/GD2 synthase. This enzyme is crucial for the biosynthesis of gangliosides, which are glycosphingolipids integral to cellular membranes, particularly in neural tissues. B4GALNT1 catalyzes the transfer of N-acetylgalactosamine (GalNAc) to glycolipids such as lactosylceramide, GM3, and GD3, resulting in the production of gangliosides GA2, GM2, and GD2 (Inamori2024Functional; Alecu2022Functional). These gangliosides play significant roles in cell signaling, interaction, and maintaining the structure and function of neural cells (Inamori2024Functional).

In healthy human cells, B4GALNT1 is essential for the proper expression of gangliosides on the cell surface, which are involved in cell signaling and interaction. This process is particularly important in the nervous system, where gangliosides contribute to the stability and function of myelinated axons, crucial for normal neurological function (Inamori2024Functional). The enzyme is primarily active in the Golgi apparatus, where it facilitates the biosynthesis of complex gangliosides, ensuring proper cellular communication and neurological health (Inamori2024Functional; Alecu2022Functional).

## Clinical Significance
Mutations in the B4GALNT1 gene are associated with hereditary spastic paraplegia type 26 (SPG26), a complex neurodegenerative disorder. SPG26 is characterized by early-onset gait difficulties, spasticity of the lower limbs, increased reflexes, and bilateral Babinski sign. Additional symptoms may include pseudobulbar dysarthria, cognitive impairment, cerebellar and extrapyramidal signs, bladder disturbances, scoliosis, and psychiatric features (Boukhris2013Alteration). The condition has been observed in various populations, including a large consanguineous Bedouin family, and is linked to distinct mutations in the B4GALNT1 gene (Li2018Congenital).

Biochemical studies have shown that mutations in B4GALNT1 lead to altered ganglioside biosynthesis, with decreased levels of GM2 and increased levels of GM3 in affected individuals. This imbalance affects the central nervous system's development and function (Harlalka2013Mutations). The disease progression is generally slow, with some individuals becoming wheelchair-bound or bedridden over time (Li2018Congenital).

Research has identified several missense variants in the B4GALNT1 gene, such as p.Asp313Asn, which impair enzyme activity and affect ganglioside synthesis, contributing to the clinical features of SPG26 (Inamori2024Functional). These findings underscore the importance of B4GALNT1 in maintaining normal neurological function and highlight its role in hereditary spastic paraplegia.

## Interactions
The B4GALNT1 protein, also known as beta-1,4-N-acetyl galactosaminyltransferase 1, is involved in protein-protein interactions, primarily studied using the STRING database. This database predicts interactions based on various evidence channels, including genomic context and functional genomics. B4GALNT1 has been shown to interact with several proteins, including ST8SIA5, SLC33A1, and GLB1. Among these, the interaction with ST8SIA5 is particularly strong, with a high confidence score of 0.977, indicating a significant predicted interaction (Dad2017Structural; Szklarczyk2020The).

The study of B4GALNT1 interactions has primarily focused on its role in the synthesis of gangliosides, which are crucial for neural tissue function. While the research has extensively explored protein-protein interactions, there is no specific mention of B4GALNT1 interacting with nucleic acids. The interactions are likely related to its enzymatic function in glycosylation pathways, where it may participate in multiprotein complexes that regulate these processes (Dad2017Structural; Inamori2024Functional). Despite the detailed analysis of its interactions, the physical interactions of B4GALNT1 with other proteins or nucleic acids remain largely predicted and not experimentally confirmed.


## References


[1. (Inamori2024Functional) Kei-ichiro Inamori, Katsuya Nakamura, Fumi Shishido, Jia-Chen Hsu, Masakazu Nagafuku, Takahiro Nitta, Junji Ikeda, Hidekane Yoshimura, Minori Kodaira, Naomi Tsuchida, Naomichi Matsumoto, Satoshi Uemura, Shiho Ohno, Noriyoshi Manabe, Yoshiki Yamaguchi, Akira Togayachi, Kiyoko F. Aoki-Kinoshita, Shoko Nishihara, Jun-ichi Furukawa, Tadashi Kaname, Masahiko Nakamura, Takayoshi Shimohata, Shu Tadaka, Matsuyuki Shirota, Kengo Kinoshita, Yutaka Nakamura, Isao Ohno, Yoshiki Sekijima, and Jin-ichi Inokuchi. Functional evaluation of novel variants of b4galnt1 in a patient with hereditary spastic paraplegia and the general population. Frontiers in Neuroscience, July 2024. URL: http://dx.doi.org/10.3389/fnins.2024.1437668, doi:10.3389/fnins.2024.1437668. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnins.2024.1437668)

[2. (Boukhris2013Alteration) Amir Boukhris, Rebecca Schule, José L. Loureiro, Charles Marques Lourenço, Emeline Mundwiller, Michael A. Gonzalez, Perrine Charles, Julie Gauthier, Imen Rekik, Rafael F. Acosta Lebrigio, Marion Gaussen, Fiorella Speziani, Andreas Ferbert, Imed Feki, Andrés Caballero-Oteyza, Alexandre Dionne-Laporte, Mohamed Amri, Anne Noreau, Sylvie Forlani, Vitor T. Cruz, Fanny Mochel, Paula Coutinho, Patrick Dion, Chokri Mhiri, Ludger Schols, Jean Pouget, Frédéric Darios, Guy A. Rouleau, Wilson Marques, Alexis Brice, Alexandra Durr, Stephan Zuchner, and Giovanni Stevanin. Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. The American Journal of Human Genetics, 93(1):118–123, July 2013. URL: http://dx.doi.org/10.1016/j.ajhg.2013.05.006, doi:10.1016/j.ajhg.2013.05.006. This article has 153 citations.](https://doi.org/10.1016/j.ajhg.2013.05.006)

[3. (Alecu2022Functional) Julian Emanuel Alecu, Yuhsuke Ohmi, Robiul H. Bhuiyan, Kei‐ichiro Inamori, Takahiro Nitta, Afshin Saffari, Hellen Jumo, Marvin Ziegler, Claudio Melo de Gusmao, Nutan Sharma, Shiho Ohno, Noriyoshi Manabe, Yoshiki Yamaguchi, Mariko Kambe, Keiko Furukawa, Mustafa Sahin, Jin‐ichi Inokuchi, Koichi Furakawa, and Darius Ebrahimi‐Fakhari. Functional validation of novel variants in <scp>b4galnt1</scp> associated with early‐onset complex hereditary spastic paraplegia with impaired ganglioside synthesis. American Journal of Medical Genetics Part A, 188(9):2590–2598, July 2022. URL: http://dx.doi.org/10.1002/ajmg.a.62880, doi:10.1002/ajmg.a.62880. This article has 5 citations.](https://doi.org/10.1002/ajmg.a.62880)

[4. (Dad2017Structural) Rubina Dad, Uzma Malik, Aneela Javed, Berge A. Minassian, and Muhammad Jawad Hassan. Structural annotation of beta-1,4- n -acetyl galactosaminyltransferase 1 (b4galnt1) causing hereditary spastic paraplegia 26. Gene, 626:258–263, August 2017. URL: http://dx.doi.org/10.1016/j.gene.2017.05.041, doi:10.1016/j.gene.2017.05.041. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2017.05.041)

[5. (Harlalka2013Mutations) Gaurav V. Harlalka, Anna Lehman, Barry Chioza, Emma L. Baple, Reza Maroofian, Harold Cross, Ajith Sreekantan-Nair, David A. Priestman, Saeed Al-Turki, Meriel E. McEntagart, Christos Proukakis, Louise Royle, Radoslaw P. Kozak, Laila Bastaki, Michael Patton, Karin Wagner, Roselyn Coblentz, Joy Price, Michelle Mezei, Kamilla Schlade-Bartusiak, Frances M. Platt, Matthew E. Hurles, and Andrew H. Crosby. Mutations in b4galnt1 (gm2 synthase) underlie a new disorder of ganglioside biosynthesis. Brain, 136(12):3618–3624, October 2013. URL: http://dx.doi.org/10.1093/brain/awt270, doi:10.1093/brain/awt270. This article has 120 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awt270)

[6. (Szklarczyk2020The) Damian Szklarczyk, Annika L Gable, Katerina C Nastou, David Lyon, Rebecca Kirsch, Sampo Pyysalo, Nadezhda T Doncheva, Marc Legeay, Tao Fang, Peer Bork, Lars J Jensen, and Christian von Mering. The string database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Research, 49(D1):D605–D612, November 2020. URL: http://dx.doi.org/10.1093/nar/gkaa1074, doi:10.1093/nar/gkaa1074. This article has 4498 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkaa1074)

[7. (Li2018Congenital) T. August Li and Ronald L. Schnaar. Congenital Disorders of Ganglioside Biosynthesis, pages 63–82. Elsevier, 2018. URL: http://dx.doi.org/10.1016/bs.pmbts.2018.01.001, doi:10.1016/bs.pmbts.2018.01.001. This article has 27 citations.](https://doi.org/10.1016/bs.pmbts.2018.01.001)